Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib + Gemcitabine + Radiotherapy in Pancreatic Cancer
NCT00234416Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in pancreatic cancer (PC), sponsored by AstraZeneca. Started Aug 2002; status: completed.
02
Drugs
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00234416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234416.